ICD-10 Coding for B-cell Lymphoma(C83.3, C83.30, C83.30B)
Learn about the ICD-10 coding for B-cell lymphoma, including remission status and documentation requirements for accurate medical coding.
Complete code families applicable to B-cell Lymphoma
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C83.30 | Diffuse large B-cell lymphoma, unspecified site | Use when DLBCL is confirmed but the specific site is not documented. |
|
| C83.3A | Diffuse large B-cell lymphoma in remission | Use for patients in remission post-treatment with documented evidence. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutB-cell Lymphoma
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting B-cell Lymphoma.
Failing to document remission status accurately.
Impact
Clinical: May affect treatment decisions., Regulatory: Non-compliance with coding standards., Financial: Potential reimbursement issues.
Mitigation
Regularly update patient records with remission status., Use standardized templates for documentation.
Using unspecified codes when specific details are available.
Impact
Reimbursement: May lead to incorrect DRG assignment., Compliance: Non-compliance with coding guidelines., Data Quality: Decreases accuracy of clinical data.
Mitigation
Always document and code the specific site and status of the lymphoma.
Remission Documentation
Impact
Inadequate documentation of remission status.
Mitigation
Ensure all remission claims are supported by clinical evidence.